https://www.selleckchem.com/products/u73122.html
We read with interest the letter by Liu et al. on portal venous (PV) thrombosis after laparoscopic sleeve gastrectomy (SG) in liver transplant recipients (1). The authors report two cases of PV thrombosis after SG in liver transplant recipients who both received enoxaparin in hospital, while only one had enoxaparin 40 mg/day for 10 days after discharge. Low molecular weight heparin (LMWH) represents the most used treatment to prevent deep venous thrombosis (DVT) and pulmonary embolism (PE) after bariatric surgery, and its use has a ratio
Like
Comment
Share
